Malcolm Jonathan, Gruszka-Goh Marta, Donachie Paul Hj, Buchan John C
Leeds Teaching Hospitals NHS Trust, Leeds, UK.
The Royal College of Ophthalmologists' National Ophthalmology Database Audit, London, UK.
Eye (Lond). 2025 Mar;39(4):779-784. doi: 10.1038/s41433-024-03494-3. Epub 2024 Nov 23.
Understanding the financial and environmental impact of clinical pathways is important for designing sustainable services. This study aimed to compare the cost and carbon footprint of sub-Tenon's and topical anaesthesia for cataract surgery, benchmark minimum topical anaesthesia utilisation rates, and quantify the benefits of increased topical anaesthesia usage in the United Kingdom National Health Service (NHS).
The cost and carbon footprint of products and staffing for topical and sub-Tenon's anaesthesia for cataract surgery were calculated and applied to National Ophthalmology Database audit data. A mainly process-based approach was used to estimate the carbon dioxide equivalent (CO2e) of product production, usage, and waste disposal.
The typical CO2e per case was 0.71 kg for topical anaesthesia and 1.19 kg for sub-Tenon's anaesthesia. Around a third of CO2e was generated by usage of unneccesary equiptment and wasteful practices. The typical cost per case was £14.60-£17.14 for topical anaesthesia, £27.74 for sub-Tenon's anaesthesia performed by an operating department practitioner and £56.15 for sub-Tenon's anaesthesia performed by a consultant anaesthetist. It is estimated that around 25,000 NHS cataract cases could annually be converted from sub-Tenon's to topical anaesthesia, which would reduce the CO2e emissions of services by 12,000 kg while saving £265,000 on product usage and between £63,500 and £773,750 on staffing.
Topical anaesthesia is a cheaper and more environmentally sustainable alternative to sub-Tenon's anaesthesia for cataract surgery. Increased topical anaesthesia usage in cataract services could contribute towards the NHS aspiration of becoming "net zero" by 2040.
了解临床路径的财务和环境影响对于设计可持续服务至关重要。本研究旨在比较白内障手术中球后麻醉和表面麻醉的成本及碳足迹,确定表面麻醉的最低使用率基准,并量化在英国国家医疗服务体系(NHS)中增加表面麻醉使用量的益处。
计算白内障手术中表面麻醉和球后麻醉的产品及人员配备的成本和碳足迹,并将其应用于国家眼科数据库的审计数据。主要采用基于流程的方法来估算产品生产、使用和废物处理的二氧化碳当量(CO2e)。
表面麻醉每例的典型CO2e为0.71千克,球后麻醉为1.19千克。约三分之一的CO2e是由使用不必要的设备和浪费行为产生的。表面麻醉每例的典型成本为14.60 - 17.14英镑,由手术室从业人员进行的球后麻醉为27.74英镑,由麻醉科顾问进行的球后麻醉为56.15英镑。据估计,NHS每年约25,000例白内障手术病例可从球后麻醉改为表面麻醉,这将使服务的CO2e排放量减少12,000千克,同时在产品使用方面节省265,000英镑,在人员配备方面节省63,500至773,750英镑。
对于白内障手术,表面麻醉是比球后麻醉更便宜且更具环境可持续性的选择。在白内障服务中增加表面麻醉的使用量有助于NHS实现到2040年“净零”的目标。